detection of bacterial pathogens by phage antibody...
TRANSCRIPT
99
Detection of bacterial pathogens by phageantibody display
Namrata Paia, Katherine P. Toppinga,John Greenmanb and Timothy A. Pageta,∗aDept. of Biological Sciences, and bDept. of Surgery,The University of Hull, Hull HU6 7RX, UK
1. Introduction
Vibrio parahaemolyticus is a halophilic Gram-negative facultative anaerobe commonly found in estu-arine waters and in seafood like shellfish. It has beenimplicated in outbreaks of gastro-enteritis in severalcountries [1]. Food borne illness caused by V. para-haemolyticus results chiefly from the consumption ofinsufficiently heated or raw seafood, especially in thesummer months. The standard method for detection ofV. parahaemolyticus (Bacteriological Analytical Man-ual procedure) is a culture-based procedure which cantake up to four days for positive identification.
Recent outbreaks of V. parahaemolyticus related ill-nesses have heightened the need to develop a rapidand reliable method to detect this pathogen in shell-fish. PCR methods, based on the amplification of thetoxin producing genes, unfortunately give false pos-tive results with other Vibrio species [2]. In our stud-ies we have used phage antibody display to differenti-ate between pathogenic V. parahaemolyticus and otherpathogenic and non-pathogenic Vibrio sp.
2. Methods
2.1. Bacterial cultures
Cultures of V. parahaemolyticus and other Vibrio sp.were obtained from the National Collection of TypeCultures, London and the ATCC.
∗Correspondence to: Dr. Timothy Paget, Dept. of Biologi-cal Sciences, Hardy Building, The University of Hull, Hull HU67RX, UK. Tel.: +44 1428 465506; Fax: +44 1482 466996; E-mail:[email protected].
2.2. Panning
The human synthetic scFv (NISSIM) library wasused as a source of antibody fragments of differentspecificities (greater than 108) [3].
Five rounds of panning were used to select forantibodies specific for surface markers on V. para-haemolyticus. Pooled cultures of V. parahaemolyti-cus (cell density = 8 × 108 cells/ml at A600) wereused in 4 rounds of positive panning. One round ofnegative panning was carried out using pooled cul-tures of non-parahaemolyticus Vibrios (cell density= 8×108 cells/ml at A600) to try and remove all cross-reactive phage.
The negative panning step was carried out after thefirst round of positive panning. The titre of eluted phagewas checked after each round of panning.
2.3. ELISA
ELISA was used to determine binding specificity ofphage clones. Phage clones after the 5th (and last)round of panning were grown up in 96-well round bot-tom ELISA plates overnight.
Flat bottom 96-well ELISA plates were coated with108 cells/well of different strains of V. parahaemolyti-cus and strains of other non-parahaemolyticus sp.overnight. Phage supernatant was obtained by grow-ing up individual phage clones overnight at 30 ◦C andthen spinning the cells at 2500 rpm for 10 minutes.Supernatant containing phage antibody was added tothe wells and the phage were allowed to bind for 2hours. Excess unbound phage was then washed off,and the bound phage detected by adding anti-M13 HRPconjugated antibody for 1 hour followed by the ad-dition of tetramethylbenzidine (TMB) substrate. Theabsorbance was measured at 450 nm using an ELISAreader (MRX microplate reader, Dynex technologies).Irrelevant phage (anti-NIP) was used as a negative con-trol.
Disease Markers 16 (2000) 99–100ISSN 0278-0240 / $8.00 2000, IOS Press. All rights reserved
100 N. Pai et al. / Detection of bacterial pathogens by phage antibody display
Table 1ELISA (Absorbance at 450nm) of phage clones binding to differentstrains of Vibrio sp
1 2 3 4 5 6 7 8
A * * * * * *B * * * * ✸ *C * * * * � * � �D * * *E * * * *F * * * � * *
Key: Readings greater than 1.000 at A450 have been consideredpositive.✸ = Vibrio parahaemolyticus NCTC 10884.* = Vibrio parahaemolyticus NCTC 10903 + NCTC 10884 (1 : 1ratio).� = Vibrio mimicus NCTC 11346 and Vibrio harveyi NCTC 11435(1 : 1 ratio) (cultures used for negative panning).
Table 2Binding percentages of selected phage antibodies against Vibrio sp.(Percentage binding of anti-NIP was used as blank)
Clone Vibrio Vibrioparahaemolyticus parahaemolyticus
NCTC 10903 NCTC 10884
A1 11.3% 7.7%B3 21.3% 21.9%B5 27.6% 27.8%C2 33% 30.5%E3 16.6% 12.5%F7 16.9% 8.15%
2.4. FACS analysis
Repeatedly strong binding clones were selected forscreening their binding properties using a FACSCaliburflow cytometer. Single cultures of V. parahaemolyticusas well as pooled cultures were used for analysis.
3. Results
After the final round of panning, 48 clones werepicked for screening by ELISA. ELISA was carried outusing individual cultures of V. parahaemolyticus NCTC10903 and V. parahaemolytiucs NCTC 10884 as wellas pooled cultures mixed in a ratio of 1 : 1. Cell densitywas maintained at 108 cells/well. Out of 48 clones, 28
clones showed repeated strong binding to both strainsof V. parahaemolyticus. Preliminary results have beenshown in Table 1. Clone B6 was the only clone that waspositive with V. parahaemolyticus NCTC 10884 andnegative with NCTC 10903. It may therefore representa clone that is strain specific.
ELISA was also carried out using pooled cultures ofV. mimicus NCTC 11346 and V. harveyi NCTC 11435in a 1 : 1 ratio. Only four clones of the 28 were crossreactive with the above cultures.
CDR3 insert size was determined using PCR as pre-viously described [3]. BstN1 restriction digestion of aPCR fragment covering the whole scFv region was alsocarried out as previously described [4].
Six phage clones out of the 28 were picked at ran-dom and were analyzed for their binding specificitiesusing flow cytometry. All 6 clones were positive for V.parahaemolyticus on FACS analysis. The percentagebinding to each strain was also determined (Table 2).
4. Discussion
Using phage display, we have been able to isolateantibodies that bind to V. parahaemolyticus. We arenow in the process of screening these antibodies againsta broad range of Vibrio and other related sp., fromdifferent sources, to determine their specificity.
References
[1] CDC, Outbreak of Vibrio parahaemolyticus infections associ-ated with eating raw oysters – Pacific Northwest, 1997, MMWRMorbidity and Mortality Weekly Report 47(22) (1998), 457–462.
[2] Y.B. Kim et al., Identification of V. parahaemolyticus strains atthe species level by PCR targetted to the toxR gene, Journal ofClinical Microbiology 37(4) (1999), 1173–1177.
[3] A. Nissim, H.R. Hoogenboom and I.M. Tomlinson et al., An-tibody fragments from a “single pot” phage display library asimmunochemical reagents, EMBO J. 13 (1994), 628–629.
[4] J. Marks, H. Hoogenboom and T. Bonnert et al., Human anti-bodies from phage display libraries, Journal of Molecular Bi-ology 222 (1991), 581–597.
Submit your manuscripts athttp://www.hindawi.com
Stem CellsInternational
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
MEDIATORSINFLAMMATION
of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Behavioural Neurology
EndocrinologyInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
BioMed Research International
OncologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Oxidative Medicine and Cellular Longevity
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
PPAR Research
The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014
Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
ObesityJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Computational and Mathematical Methods in Medicine
OphthalmologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Diabetes ResearchJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Research and TreatmentAIDS
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Gastroenterology Research and Practice
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Parkinson’s Disease
Evidence-Based Complementary and Alternative Medicine
Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com